Biotech: The Ultimate Impact Investment? | TIGER 21 Chair Featured in Financial Times
Share on Social
![](https://s44071.pcdn.co/wp-content/uploads/2023/06/AdobeStock_399530098-scaled.jpeg.optimal.jpeg)
Orlando TIGER 21 Chair Eric Casaburi was recently featured in the Financial Times, where he shared his insights on how the ultra-high-net-worth community is currently approaching biotech investing and the tremendous movement into the healthcare space. A survey of TIGER 21 Members found that nearly 25% planned to invest in healthcare this year.
The emphasis on healthcare is reflected in the flow of family office money into venture capital. Despite the potential risk if a treatment does not work, the rewards in healthcare can be substantial, making it an impact investment.
About TIGER 21
TIGER 21 is an exclusive global community of ultra-high-net-worth entrepreneurs, investors, and executives.
Explore the TIGER 21 Member ExperienceTags
Member Insight Reports
![](https://s44071.pcdn.co/wp-content/uploads/2020/02/TIGER-21-Insights-Placeholder-Image.png)